Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor?
- 1 January 1993
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 165 (1) , 61-67
- https://doi.org/10.1016/s0002-9610(05)80405-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tumor removal improved glucose metabolism in humansClinical Nutrition, 1992
- The diabetes in pancreatic cancer patients is associated with a marked increase in islet amyloid polypeptide secretionRegulatory Peptides, 1992
- CLINICAL REVIEW 26 Insulin Resistance in Obese and Nonobese ManJournal of Clinical Endocrinology & Metabolism, 1991
- Treatment with a Somatostatin Analog Decreases Pancreatic B-Cell and Whole Body Sensitivity to Glucose*Journal of Clinical Endocrinology & Metabolism, 1990
- Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitroNature, 1988
- Insulin resistance in patients with colorectal cancerBritish Journal of Surgery, 1987
- Developmental pattern of TRH-degrading activity and TRH content in rat pancreasActa Endocrinologica, 1984
- Glucagon and the a CellNew England Journal of Medicine, 1981
- A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinomaDigestive Diseases and Sciences, 1978
- Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice.Journal of Clinical Investigation, 1976